Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three- dimensional conformal radiotherapy Academic Article uri icon

Overview

MeSH Major

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Prostatic Neoplasms
  • Radiotherapy, Computer-Assisted

abstract

  • For patients treated with NAAD and high-dose 3D-CRT, pretreatment PSA, preradiotherapy PSA nadir response, and clinical stage are important predictors of biochemical outcome. Patients with NAAD-induced PSA nadir levels greater than 0.5 ng/mL before radiotherapy are more likely to develop biochemical failure and may benefit from more aggressive therapies.

publication date

  • October 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9779716

Additional Document Info

start page

  • 3380

end page

  • 5

volume

  • 16

number

  • 10